TL;DR
The prognosis for macular degeneration varies a great deal depending on which type you have, how early it’s caught and what treatment is available. Some people live with the condition for years with very little impact on their daily life, while others experience faster, more serious vision loss. Knowing what to expect at each stage can help you plan ahead and make informed decisions about your care.
Dry AMD: Slow progression, but it doesn’t stand still
Around 80-90% of people with age-related macular degeneration have the dry form. In its early stages, dry AMD often causes no noticeable symptoms at all. Your optician might spot small yellow deposits called drusen during a routine eye exam, but your vision may feel completely normal.
As dry AMD moves into its intermediate stage, you might start to notice mild blurriness or that you need more light to read comfortably. This progression typically happens over years, not months, and many people at this stage still manage everyday tasks without major difficulty.
The concern with dry AMD is what happens in the later stages. Around 20% of people with dry AMD will eventually develop geographic atrophy (GA), an advanced form where patches of retinal cells die off permanently. GA is irreversible and tends to expand over time, with lesions growing at an average rate of roughly 1.5 to 2 square millimetres per year. That might sound small, but because the affected area is at the very centre of your vision, even modest growth can make reading, driving and recognising faces significantly harder.
For people with bilateral GA, the outlook can be more challenging. Research suggests that around 16% of patients with GA in both eyes become legally blind within about six years of diagnosis. On the other hand, many people with GA retain enough peripheral vision to remain independent, and the condition never leads to total blindness.
Wet AMD: More aggressive, but treatable
Wet AMD accounts for only 10-15% of all AMD cases, but it’s responsible for the majority of severe vision loss from the disease. It develops when abnormal blood vessels grow beneath the macula and begin leaking fluid or blood. This can cause rapid and significant damage to central vision, sometimes within weeks.
Before effective treatments were available, the prognosis for wet AMD was poor. Most people experienced progressive vision loss, and many became legally blind within a few years of diagnosis. That picture has changed dramatically since the introduction of anti-VEGF injections in the mid-2000s.
Anti-VEGF drugs work by blocking the protein that triggers abnormal blood vessel growth. When treatment starts promptly, most patients can stabilise their vision, and a meaningful proportion see some improvement. Clinical studies consistently show that around two thirds of treated patients maintain their vision over three years, with some gaining back several lines on the eye chart.
The catch is that treatment needs to be ongoing. Wet AMD typically requires regular injections, sometimes monthly at first and then at longer intervals depending on how your eye responds. Patients who keep up with their appointments tend to do well, but those who miss follow-ups or stop treatment early are at significantly higher risk of losing vision. One study found that patients who were lost to follow-up for more than six months had considerably worse long-term outcomes than those who attended regularly.
What affects your individual prognosis?
No two cases of AMD follow the same path. Several factors can influence how the condition behaves in your eyes specifically.
The stage at diagnosis
This is the most important variable. If AMD is caught at an early or intermediate stage, you have more time and more options. The AREDS2 study showed that a specific combination of nutrients, including lutein, zeaxanthin, zinc, copper and vitamins C and E, can reduce the risk of intermediate dry AMD progressing to an advanced stage by around 25%. That’s a significant difference, but it only applies if the condition is detected in time.
Which eye is affected
AMD often starts in one eye before the other. If only one eye is affected, your overall functional vision will be much better because the stronger eye compensates. But if the condition develops in both eyes, which happens in a significant proportion of people over time, the impact on daily life becomes more pronounced.
Your lifestyle
Smoking is the single biggest modifiable risk factor for AMD. It accelerates progression of both dry and wet forms and is estimated to increase the rate of geographic atrophy by two to four times. Quitting at any stage is one of the most effective things you can do to protect your remaining vision.
Diet, exercise, blood pressure management and UV protection all play supporting roles too. None of these will reverse existing damage, but they can help slow down the rate at which the condition advances.
Will macular degeneration make me completely blind?
This is one of the most common fears people have after a diagnosis, and the answer is reassuring. Macular degeneration affects central vision, but it doesn’t damage peripheral vision. Even in advanced stages, most people retain the ability to see around the edges of their visual field, which means they can still move around, recognise environments and maintain a degree of independence.
That said, losing central vision is a serious matter. It makes tasks like reading, driving, watching television and recognising faces much harder, and it can have a real impact on quality of life and mental wellbeing. Some people with advanced AMD also experience Charles Bonnet syndrome, a condition where the brain generates visual hallucinations to fill in the gaps left by lost vision. This can be unsettling, but it’s not a sign of mental illness and it often improves over time.
Related read: What Percentage Of Macular Degeneration Patients Go Blind?
What you can do right now
If you’ve been diagnosed with AMD, or if you’re at risk because of your age or family history, the most important step is to stay engaged with your eye care. Regular eye exams allow your optician or ophthalmologist to track any changes and act quickly if the condition progresses.
Monitoring your own vision at home with an Amsler grid is a simple habit that can make a real difference. Any new distortion or blank patches should be reported to your eye care professional immediately, as they could signal a change from dry to wet AMD that needs urgent treatment.
And if you’re living with vision loss from AMD, ask about low vision aids and support services. Magnifiers, screen readers, brighter lighting and occupational therapy can all help you adapt and continue doing the things that matter to you.
